Navigation Links
More grapes, less wrath: Hybrid antimicrobial protein protects grapevines from pathogen

LOS ALAMOS, New Mexico, February 20, 2012A team of researchers has found a way to ensure that your evening glass of wine will continue to be available, despite the potential attack of Xylella fastidiosa (Xf), a bacterium that causes Pierce's Disease and poses a significant threat to the California wine industry's valuable grapevines.

Researchers from Los Alamos National Laboratory (LANL), University of California at Davis (UCD), and the U.S. Department of Agriculture's Agricultural Research Service have created specially engineered grapevines that produce a hybrid antimicrobial protein that can block Xf infection.

Their research is published in the current edition of Proceedings of the National Academy of Sciences, "An engineered innate immune defense protects grapevines from Pierce's disease," by Abhaya M. Dandekar, et al. The article's online tracking number is 2011-16027R in the PNAS Early Edition to be published the week of Feb. 20, 2012.

By helping the vine fight the microbe with specific proteins, the scientists envision vineyards requiring less reliance on chemicals as growers seek to fend off the bacterium and the glassy-winged sharpshooter (Homalodisca vitripennis) insect that carries it. As the insect feeds on various plants, it distributes the microbe widely.

The key to the project's success is the fact that early in an Xf infection, molecules on the outer membrane of the microbe interact with cells of the grapevine. By interfering with that interaction between microbe and vine, scientists can help the vines block the disease and go on to produce a healthy crop of grapes.

"One thing got us started: with almost any pathogen, the major problem is drug resistance," said Goutam Gupta, the corresponding author of the PNAS paper. "We wanted the plant to clear itself of the pathogen before it is infected, much as the body's immune system naturally recognizes a pathogen and takes action to defeat it."

To make the effective protein, researchers fused two genes: one that encodes a protein to cut a specific molecule on the outer membrane of Xf, and another that triggers the bursting of the Xf bacterium's outer wall, called lysis.

The team inserted the hybrid gene into grapevines and observed the plants' response to Xf infection. "The hybrid protein apparently creates pores in the membrane of the Gram-negative bacterium, Xf," said Gupta, thus allowing the plant to fight back the infection. Sap from the engineered plants successfully killed Xf in laboratory tests, and the whole plants did not exhibit symptoms of Pierce's disease after exposure to the Xf bacterium.

The antimicrobial gene may also protect other economically important plants from Xf-related diseases, and a similar strategy may be effective against a broad range of pathogen-induced plant and human diseases, Gupta said. X. fastidiosa is implicated in oleander leaf scorch, phony peach disease, plum leaf scald, almond leaf scorch, Pierce's disease in grapes, and citrus X disease in Brazil.


Contact: Nancy Ambrosiano
DOE/Los Alamos National Laboratory

Related biology news :

1. New hybrid plants could prompt more prodigious pepper production in Southwest
2. Hybrid vehicle rebates produce scant environmental benefits, high cost
3. Rice researchers make graphene hybrid
4. Single gene dramatically boosts yield, sweetness in tomato hybrids, CSHL-Israeli study finds
5. Genetic key discovered to dramatically increase yields and improve taste of hybrid tomato plants
6. Liposome-hydrogel hybrids: No toil, no trouble for stronger bubbles
7. What causes hybrid vigor?
8. ISU researchers develop hybrid protein tools for gene cutting and editing
9. Hard-wired for chocolate and hybrid cars? How genetics affect consumer choice
10. If GMO genes escape, how will the hybrids do?
11. Potential hemlock hybrids tolerant to invasive hemlock woolly adelgid
Post Your Comments:
Related Image:
More grapes, less wrath: Hybrid antimicrobial protein protects grapevines from pathogen
(Date:4/28/2016)... First quarter 2016:   , ... the first quarter of 2015 The gross margin was ... 18.8) and the operating margin was 40% (-13) Earnings ... flow from operations was SEK 249.9 M (21.2) , ... SEK 7,000-8,500 M. The operating margin for 2016 is ...
(Date:4/15/2016)... April 15, 2016 Research ... Gait Biometrics Market 2016-2020,"  report to their offering.  ... ) , ,The global gait biometrics market is ... during the period 2016-2020. Gait analysis ... can be used to compute factors that are ...
(Date:3/29/2016)... BOCA RATON, Florida , March 29, 2016 /PRNewswire/ ... ("LegacyXChange" or the "Company") LegacyXChange "LEGX" and SelectaDNA/CSI Protect ... Synthetic DNA in ink used in a variety of ... preventing theft. Buyers of originally created collectibles from athletes ... authenticity through forensic analysis of the DNA. ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... , June 23, 2016 /PRNewswire/ - FACIT ... Ontario biotechnology company, Propellon Therapeutics ... development and commercialization of a portfolio of first-in-class ... Epigenetic targets such as WDR5 represent an exciting ... significantly in precision medicine for cancer patients. Substantial ...
(Date:6/23/2016)... YORK , June, 23, 2016  The Biodesign ... to envision new ways to harness living systems and ... Modern Art (MoMA) in New York City ... than 130 participating students, showcased projects at MoMA,s Celeste ... Paola Antonelli , MoMA,s senior curator of architecture ...
(Date:6/23/2016)... , June 23, 2016 Apellis ... Phase 1 clinical trials of its complement C3 ... single and multiple ascending dose studies designed to ... (PD) of subcutaneous injection in healthy adult volunteers. ... (SC) either as a single dose (ranging from ...
(Date:6/23/2016)... ... June 23, 2016 , ... Regulatory Compliance ... consulting, provides a free webinar on Performing Quality Investigations: Getting to ... 12pm CT at no charge. , Incomplete investigations are still a major concern ...
Breaking Biology Technology: